High-throughput characterization of the functional impact of IgG Fc glycan aberrancy in juvenile idiopathic arthritis

Glycobiology

Volumn 27, Issue 12, 2017, Pages 1099-1108

  Cheng, Hao D ^a   Stöckmann, Henning ^b   Adamczyk, Barbara ^b   McManus, Ciara A ^b   Ercan, Altan ^c   Holm, Ingrid A ^d   Rudd, Pauline M ^c   Ackerman, Margaret E ^a,e   Nigrovic, Peter A ^c,d  

^a DARTMOUTH COLLEGE   (United States)

^b NATIONAL INSTITUTE FOR BIOPROCESSING RESEARCH AND TRAINING   (Ireland)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e DARTMOUTH COLLEGE   (United States)

Author keywords

FcRL5; IgG glycan; IgG receptor binding; Juvenile idiopathic arthritis; Machine learning

Indexed keywords

FC RECEPTOR; FCRL5 PROTEIN, HUMAN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G;

ADOLESCENT; ANTIBODY COMBINING SITE; BLOOD; CHILD; CLINICAL TRIAL; FEMALE; GLYCOSYLATION; HUMAN; IMMUNOLOGY; INFANT; JUVENILE RHEUMATOID ARTHRITIS; MALE; MULTICENTER STUDY; PRESCHOOL CHILD;

ADOLESCENT; ARTHRITIS, JUVENILE; BINDING SITES, ANTIBODY; CHILD; CHILD, PRESCHOOL; FEMALE; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; INFANT; MALE; RECEPTORS, FC;

EID: 85044660094     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwx082     Document Type: Article

References (82)

1. Ackerman ME, Crispin M, Yu X, Baruah K, Boesch AW, Harvey DJ, Dugast AS, Heizen EL, Ercan A, Choi I et al. 2013. Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. J Clin Invest. 123:2183-2192.
2. Anthony RM, Kobayashi T, Wermeling F, Ravetch JV. 2011. Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway. Nature. 475:110-113.
3. Anthony RM, Ravetch JV. 2010. A novel role for the IgG Fc glycan: The anti-inflammatory activity of sialylated IgG Fcs. J Clin Immunol. 30(Suppl 1):S9-S14.
4. Anthony RM, Wermeling F, Karlsson MC, Ravetch JV. 2008. Identification of a receptor required for the anti-inflammatory activity of IVIG. Proc Nat Acad Sci USA. 105:19571-19578.
5. Arnold JN, Dwek RA, Rudd PM, Sim RB. 2006. Mannan binding lectin and its interaction with immunoglobulins in health and in disease. Immunol Lett. 106:103-110.
6. Bajpai UD, Swainson LA, Mold JE, Graf JD, Imboden JB, McCune JM. 2012. A functional variant in FCRL3 is associated with higher Fc receptor-like 3 expression on T cell subsets and rheumatoid arthritis disease activity. Arthritis Rheum. 64:2451-2459.
7. Banda NK, Hyatt S, Antonioli AH, White JT, Glogowska M, Takahashi K, Merkel TJ, Stahl GL, Mueller-Ortiz S, Wetsel R et al. 2012. Role of C3a receptors, C5a receptors, and complement protein C6 deficiency in collagen antibody-induced arthritis in mice. J Immunol (Baltimore, MD: 1950). 188:1469-1478.
8. Banda NK, Takahashi K, Wood AK, Holers VM, Arend WP. 2007. Pathogenic complement activation in collagen antibody-induced arthritis in mice requires amplification by the alternative pathway. J Immunol (Baltimore, MD: 1950). 179:4101-4109.
9. Banda NK, Thurman JM, Kraus D, Wood A, Carroll MC, Arend WP, Holers VM. 2006. Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis. J Immunol (Baltimore, MD: 1950). 177: 1904-1912.
10. Banda NK, Wood AK, Takahashi K, Levitt B, Rudd PM, Royle L, Abrahams JL, Stahl GL, Holers VM, Arend WP. 2008. Initiation of the alternative pathway of murine complement by immune complexes is dependent on N-glycans in IgG antibodies. Arthritis Rheum. 58:3081-3089.
11. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Series B (Methodological). 57:289-300.
12. Boesch AW, Brown EP, Cheng HD, Ofori MO, Normandin E, Nigrovic PA, Alter G, Ackerman ME. 2014. Highly parallel characterization of IgG Fc binding interactions. MAbs. 6:915-927.
13. Bond A, Alavi A, Axford JS, Youinou P, Hay FC. 1996. The relationship between exposed galactose and N-acetylglucosamine residues on IgG in rheumatoid arthritis (RA), juvenile chronic arthritis (JCA) and Sjogren's syndrome (SS). Clin Exp Immunol. 105:99-103.
14. Bondt A, Selman MH, Deelder AM, Hazes JM, Willemsen SP, Wuhrer M, Dolhain RJ. 2013. Association between galactosylation of immunoglobulin G and improvement of rheumatoid arthritis during pregnancy is independent of sialylation. J Proteome Res. 12:4522-4531.
15. Bondt A, Wuhrer M, Kuijper TM, Hazes JM, Dolhain RJ. 2016. Fab glycosylation of immunoglobulin G does not associate with improvement of rheumatoid arthritis during pregnancy. Arthritis Res Ther. 18:274.
16. Bowyer SL, Roettcher PA, Higgins GC, Adams B, Myers LK, Wallace C, Rennebohm R, Moore TL, Pepmueller PH, Spencer C et al. 2003. Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis. J Rheumatol. 30:394-400.
17. Brown EP, Licht AF, Dugast AS, Choi I, Bailey-Kellogg C, Alter G, Ackerman ME. 2012. High-throughput, multiplexed IgG subclassing of antigenspecific antibodies from clinical samples. J Immunol Methods. 386: 117-123.
18. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, Kwiatkowski DP, McCarthy MI, Ouwehand WH, Samani NJ et al. 2007. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 39:1329-1337.
19. Campbell IK, Miescher S, Branch DR, Mott PJ, Lazarus AH, Han D, Maraskovsky E, Zuercher AW, Neschadim A, Leontyev D et al. 2014. Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils. J Immunol (Baltimore, MD: 1950). 192:5031-5038.
20. Crispin M, Yu X, Bowden TA. 2013. Crystal structure of sialylated IgG Fc: Implications for the mechanism of intravenous immunoglobulin therapy. Proc Nat Acad Sci USA. 110:E3544-E3546.
21. Davis RS. 2015. B-1 cell development and function. Ann NY Acad Sci. 1362: 110-116.
22. de Haan N, Reiding KR, Driessen G, van der Burg M, Wuhrer M. 2016. Changes in healthy human IgG Fc-glycosylation after birth and during early childhood. J Proteome Res. 15:1853-1861.
23. Dement-Brown J, Newton CS, Ise T, Damdinsuren B, Nagata S, Tolnay M. 2012. Fc receptor-like 5 promotes B cell proliferation and drives the development of cells displaying switched isotypes. J Leukoc Biol. 91: 59-67.
24. Ehrhardt GR, Cooper MD. 2011. Immunoregulatory roles for fc receptor-like molecules. Curr Top Microbiol Immunol. 350:89-104.
25. Ehrhardt GR, Davis RS, Hsu JT, Leu CM, Ehrhardt A, Cooper MD. 2003. The inhibitory potential of Fc receptor homolog 4 on memory B cells. Proc Nat Acad Sci USA. 100:13489-13494.
26. Ercan A, Barnes MG, Hazen M, Tory H, Henderson L, Dedeoglu F, Fuhlbrigge RC, Grom A, Holm IA, Kellogg M et al. 2012a. Multiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylation. Arthritis Rheum. 64:3025-3033.
27. Ercan A, Cui J, Chatterton DE, Deane KD, Hazen MM, Brintnell W, O'Donnell CI, Derber LA, Weinblatt ME, Shadick NA et al. 2010a. Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis. Arthritis Rheum. 62:2239-2248.
28. Ercan A, Cui J, Chatterton DEW, Deane KD, Hazen MM, Brintnell W, O'Donnell CI, Derber LA, Weinblatt ME, Shadick NA et al. 2010b. IgG galactosylation aberrancy precedes disease onset, correlates with disease activity and is prevalent in autoantibodies in rheumatoid arthritis. Arthritis Rheum. 62:2239-2248.
29. Ercan A, Cui J, Hazen MM, Batliwalla F, Royle L, Rudd PM, Coblyn JS, Shadick N, Weinblatt ME, Gregersen P et al. 2012b. Hypogalactosylation of serum N-glycans fails to predict clinical response to methotrexate and TNF inhibition in rheumatoid arthritis. Arthritis Res Ther. 14:R43.
30. Ercan A, Kohrt WM, Cui J, Deane KD, Pezer M, Yu EW, Hausmann JS, Campbell H, Kaiser UB, Rudd PM et al. 2017. Estrogens regulate glycosylation of IgG in women and men. JCI Insight. 2:e89703.
31. Franco A, Damdinsuren B, Ise T, Dement-Brown J, Li H, Nagata S, Tolnay M. 2013. Human Fc receptor-like 5 binds intact IgG via mechanisms distinct from those of Fc receptors. J Immunol (Baltimore, MD: 1950). 190: 5739-5746.
32. Friedman J, Hastie T, Tibshirani R. 2010. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 33:1-22.
33. Gare BA. 1998. Epidemiology. Bailliere's Clin Rheumatol. 12:191-208.
34. Haga CL, Ehrhardt GR, Boohaker RJ, Davis RS, Cooper MD. 2007. Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment. Proc Nat Acad Sci USA. 104:9770-9775.
35. Holland M, Takada K, Okumoto T, Takahashi N, Kato K, Adu D, Ben-Smith A, Harper L, Savage CO, Jefferis R. 2002. Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis. Clin Exp Immunol. 129:183-190.
36. Holland M, Yagi H, Takahashi N, Kato K, Savage CO, Goodall DM, Jefferis R. 2006. Differential glycosylation of polyclonal IgG, IgG-Fc and IgGFab isolated from the sera of patients with ANCA-associated systemic vasculitis. Biochim Biophys Acta. 1760:669-677.
37. Hromadnikova I, Stechova K, Vavrincova P, Hridelova D, Houbova B, Voslarova S, Nekvasilova H, Vavrinec J. 2002. Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis. Autoimmunity. 35:397-401.
38. Jackson TA, Haga CL, Ehrhardt GR, Davis RS, Cooper MD. 2010. FcR-like 2 inhibition of B cell receptor-mediated activation of B cells. J Immunol (Baltimore, MD: 1950). 185:7405-7412.
39. Kaneko Y, Nimmerjahn F, Ravetch JV. 2006. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science. 313:670-673.
40. Karsten CM, Pandey MK, Figge J, Kilchenstein R, Taylor PR, Rosas M, McDonald JU, Orr SJ, Berger M, Petzold D et al. 2012. Antiinflammatory activity of IgG1 mediated by Fc galactosylation and association of FcgammaRIIB and dectin-1. Nat Med. 18:1401-1406.
41. Kochi Y, Myouzen K, Yamada R, Suzuki A, Kurosaki T, Nakamura Y, Yamamoto K. 2009. FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling. J Immunol (Baltimore, MD: 1950). 183:5502-5510.
42. Kochi Y, Yamada R, Suzuki A, Harley JB, Shirasawa S, Sawada T, Bae SC, Tokuhiro S, Chang X, Sekine A et al. 2005. A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet. 37:478-485.
43. Kodar K, Stadlmann J, Klaamas K, Sergeyev B, Kurtenkov O. 2012. Immunoglobulin G Fc N-glycan profiling in patients with gastric cancer by LC-ESI-MS: Relation to tumor progression and survival. Glycoconj J. 29:57-66.
44. Kristic J, Vuckovic F, Menni C, Klaric L, Keser T, Beceheli I, Pucic-Bakovic M, Novokmet M, Mangino M, Thaqi K et al. 2014. Glycans are a novel biomarker of chronological and biological ages. J Gerontol Series A Biol Sci Med Sci. 69:779-789.
45. LeMaoult J, Szabo P, Weksler ME. 1997. Effect of age on humoral immunity, selection of the B-cell repertoire and B-cell development. Immunol Rev. 160:115-126.
46. Li FJ, Won WJ, Becker EJ Jr, Easlick JL, Tabengwa EM, Li R, Shakhmatov M, Honjo K, Burrows PD, Davis RS. 2014. Emerging roles for the FCRL family members in lymphocyte biology and disease. Curr Top Microbiol Immunol. 382:29-50.
47. Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB. 1995. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med. 1: 237-243.
48. Manners PJ, Bower C. 2002. Worldwide prevalence of juvenile arthritis why does it vary so much?. J Rheumatol. 29:1520-1530.
49. Martinez A, Mas A, de Las Heras V, Bartolome M, Arroyo R, Fernandez-Arquero M, de la Concha EG, Urcelay E. 2007. FcRL3 and multiple sclerosis pathogenesis: Role in autoimmunity?. J Neuroimmunol. 189: 132-136.
50. Moore JS, Wu X, Kulhavy R, Tomana M, Novak J, Moldoveanu Z, Brown R, Goepfert PA, Mestecky J. 2005. Increased levels of galactose-deficient IgG in sera of HIV-1-infected individuals. AIDS. 19:381-389.
51. Moore TL, Sheridan PW, Traycoff RB, Zuckner J, Dorner RW. 1982. Immune complexes in juvenile rheumatoid arthritis: A comparison of four methods. J Rheumatol. 9:395-401.
52. Mor-Vaknin N, Kappes F, Dick AE, Legendre M, Damoc C, Teitz-Tennenbaum S, Kwok R, Ferrando-May E, Adams BS, Markovitz DM. 2011. DEK in the synovium of patients with juvenile idiopathic arthritis: Characterization of DEK antibodies and posttranslational modification of the DEK autoantigen. Arthritis Rheum. 63:556-567.
53. Nigrovic PA, Raychaudhri S, Thompson SD. in press. Genetics and the classification of arthritis in adults and children. Arthritis Rheumatol. doi:10. 1002/art.40350.
54. Nimmerjahn F, Anthony RM, Ravetch JV. 2007. Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity. Proc Nat Acad Sci USA. 104:8433-8437.
55. Ohmi Y, Ise W, Harazono A, Takakura D, Fukuyama H, Baba Y, Narazaki M, Shoda H, Takahashi N, Ohkawa Y et al. 2016. Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis. Nat Commun. 7: 11205.
56. Omtvedt LA, Royle L, Husby G, Sletten K, Radcliffe CM, Harvey DJ, Dwek RA, Rudd PM. 2006. Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans. Arthritis Rheum. 54:3433-3440.
57. Owczarczyk K, Lal P, Abbas AR, Wolslegel K, Holweg CT, Dummer W, Kelman A, Brunetta P, Lewin-Koh N, Sorani M et al. 2011. A plasmablast biomarker for nonresponse to antibody therapy to CD20 in rheumatoid arthritis. Sci Transl Med. 3:101ra192.
58. Owen CJ, Kelly H, Eden JA, Merriman ME, Pearce SH, Merriman TR. 2007. Analysis of the Fc receptor-like-3 (FCRL3) locus in Caucasians with autoimmune disorders suggests a complex pattern of disease association. J Clin Endocrinol Metab. 92:1106-1111.
59. Parekh R, Roitt I, Isenberg D, Dwek R, Rademacher T. 1988. Age-related galactosylation of the N-linked oligosaccharides of human serum IgG. J Exp Med. 167:1731-1736.
60. Parekh RB, Dwek RA, Sutton BJ, Fernandes DL, Leung A, Stanworth D, Rademacher TW, Mizuochi T, Taniguchi T, Matsuta K et al. 1985. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature. 316:452-457.
61. Parekh RB, Roitt IM, Isenberg DA, Dwek RA, Ansell BM, Rademacher TW. 1988. Galactosylation of IgG associated oligosaccharides: Reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity. Lancet (London, England). 1:966-969.
62. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM et al. 2004. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: Second revision, Edmonton, 2001. J Rheumatol. 31:390-392.
63. Pfeifle R, Rothe T, Ipseiz N, Scherer HU, Culemann S, Harre U, Ackermann JA, Seefried M, Kleyer A, Uderhardt S et al. 2017. Regulation of autoantibody activity by the IL-23-TH17 axis determines the onset of autoimmune disease. Nat Immunol. 18:104-113.
64. Prakken B, Albani S, Martini A. 2011. Juvenile idiopathic arthritis. Lancet (London, England). 377:2138-2149.
65. Pucic M, Knezevic A, Vidic J, Adamczyk B, Novokmet M, Polasek O, Gornik O, Supraha-Goreta S, Wormald MR, Redzic I et al. 2011. High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations. Mol Cell Prot MCP. 10: M111.010090.
66. Quast I, Keller CW, Maurer MA, Giddens JP, Tackenberg B, Wang LX, Munz C, Nimmerjahn F, Dalakas MC, Lunemann JD. 2015. Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity. J Clin Invest. 125:4160-4170.
67. Rademacher TW, Williams P, Dwek RA. 1994. Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc Nat Acad Sci USA. 91:6123-6127.
68. Raju TS. 2008. Terminal sugars of Fc glycans influence antibody effector functions of IgGs. Curr Opin Immunol. 20:471-478.
69. Ramirez-Bello J, Jimenez-Morales S, Espinosa-Rosales F, Gomez-Vera J, Gutierrez A, Velazquez Cruz R, Baca V, Orozco L. 2013. Juvenile rheumatoid arthritis and asthma, but not childhood-onset systemic lupus erythematosus are associated with FCRL3 polymorphisms in Mexicans. Mol Immunol. 53:374-378.
70. Rombouts Y, Ewing E, van de Stadt LA, Selman MH, Trouw LA, Deelder AM, Huizinga TW, Wuhrer M, van Schaardenburg D, Toes RE et al. 2015. Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis. Ann Rheum Dis. 74:234-241.
71. Rook GA, Steele J, Brealey R, Whyte A, Isenberg D, Sumar N, Nelson JL, Bodman KB, Young A, Roitt IM et al. 1991. Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy. J Autoimmun. 4:779-794.
72. Royle L, Campbell MP, Radcliffe CM, White DM, Harvey DJ, Abrahams JL, Kim YG, Henry GW, Shadick NA, Weinblatt ME et al. 2008. HPLCbased analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal Biochem. 376:1-12.
73. Scherer HU, Wang J, Toes RE, van der Woude D, Koeleman CA, de Boer AR, Huizinga TW, Deelder AM, Wuhrer M. 2009. Immunoglobulin 1 (IgG1) Fc-glycosylation profiling of anti-citrullinated peptide antibodies from human serum. Proteomics Clin Appl. 3:106-115.
74. Selman MH, Niks EH, Titulaer MJ, Verschuuren JJ, Wuhrer M, Deelder AM. 2011. IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis. J Proteome Res. 10:143-152.
75. Stockmann H, Adamczyk B, Hayes J, Rudd PM. 2013. Automated, highthroughput IgG-antibody glycoprofiling platform. Anal Chem. 85: 8841-8849.
76. Sullivan RT, Kim CC, Fontana MF, Feeney ME, Jagannathan P, Boyle MJ, Drakeley CJ, Ssewanyana I, Nankya F, Mayanja-Kizza H et al. 2015. FCRL5 delineates functionally impaired memory B Cells associated with Plasmodium falciparum exposure. PLoS Pathog. 11:e1004894.
77. Sumar N, Isenberg DA, Bodman KB, Soltys A, Young A, Leak AM, Round J, Hay FC, Roitt IM. 1991. Reduction in IgG galactose in juvenile and adult onset rheumatoid arthritis measured by a lectin binding method and its relation to rheumatoid factor. Ann Rheum Dis. 50:607-610.
78. van de Geijn FE, Wuhrer M, Selman MH, Willemsen SP, de Man YA, Deelder AM, Hazes JM, Dolhain RJ. 2009. Immunoglobulin G galactosylation and sialylation are associated with pregnancy-induced improvement of rheumatoid arthritis and the postpartum flare: Results from a large prospective cohort study. Arthritis Res Ther. 11:R193.
79. Vuckovic F, Kristic J, Gudelj I, Teruel M, Keser T, Pezer M, Pucic-Bakovic M, Stambuk J, Trbojevic-Akmacic I, Barrios C et al. 2015. Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome. Arthrit Rheumatol (Hoboken, NJ). 67:2978-2989.
80. Wang J, Balog CI, Stavenhagen K, Koeleman CA, Scherer HU, Selman MH, Deelder AM, Huizinga TW, Toes RE, Wuhrer M. 2011. Fc-glycosylation of IgG1 is modulated by B-cell stimuli. Mol Cell Prot. 10:M110.004655.
81. Wilson TJ, Fuchs A, Colonna M. 2012. Cutting edge: Human FcRL4 and FcRL5 are receptors for IgA and IgG. J Immunol (Baltimore, MD: 1950). 188:4741-4745.
82. Zhu Z, Li R, Li H, Zhou T, Davis RS. 2013. FCRL5 exerts binary and compartment-specific influence on innate-like B-cell receptor signaling. Proc Nat Acad Sci USA. 110:E1282-E1290.